Table 2.
Proportional Hazard Assumption Test for the Study on Incidence of Mortality and Its Predictors Among VL Patients at the University of Gondar Hospital, 2019
| Variables | Rho | Chi2 | df | Prob>chi2 |
|---|---|---|---|---|
| Residence | −0.29213 | 6,20 | 1 | 0.0127 |
| Edema | −0.19109 | 2.73 | 1 | 0.0983 |
| Diarrhea | 0.06225 | 0.28 | 1 | 0.5940 |
| Comorbidity | 0.16637 | 2.29 | 1 | 0.1305 |
| VL episode | −0.15490 | 1.77 | 1 | 0.1831 |
| Toxicity | −0.01293 | 0.01 | 1 | 0.9055 |
| Hemoglobin | −0.10120 | 0.78 | 1 | 0.3781 |
| Nasal bleeding | 0.06777 | 0.38 | 1 | 0.5398 |
| Jaundice | −0.05067 | 0.19 | 1 | 0.6626 |
| Illness duration | 0.14165 | 1.61 | 1 | 0.2039 |
| Patient condition at admission | −0.11546 | 1.22 | 1 | 0.2688 |
| Parasite level | 0.13763 | 1.63 | 1 | 0.2011 |
| Creatinine level | 0.02843 | 0.06 | 1 | 0.8060 |
| Treatment type | 0.04827 | 0.17 | 1 | 0.6793 |
| Global test | 15.30 | 14 | 0.4299 |